NEW ZEALAND GAZETTE, No. 133

28 AUGUST 2008

on 20 August 2008, for the confiscation of the following motor vehicle:

1997 Mitsubishi Galant, Registration No. CSZ837.

Against: Joyanne Hoani.

Any person having a legal interest in this vehicle should contact the Court urgently (telephone (07) 921 7400) as the Registrar may sell the vehicle.

This notice is placed pursuant to the Sentencing Regulations 2002.

K. ONEKAWA, Deputy Registrar.

go6149

New Zealand Food Safety Authority

Agricultural Compounds and Veterinary Medicines Act 1997

Notice of Application to Register a Trade Name Product (Notice No. 95)

Pursuant to section 14(1) of the Agricultural Compounds and Veterinary Medicines Act 1997, the Director-General of the New Zealand Food Safety Authority gives notice that the following application has been made to register a trade name product under section 9(1) of the Agricultural Compounds and Veterinary Medicines Act 1997:

Trade Name: Bomatak LAC Sheep Oral Mineralised

Reference: A10189

Active Ingredients and Concentrations:
Each litre contains

• Levamisole HCI 40g
• Closantel 50g
• Albendazole 25g
• Copper 2.5g
• Zinc 1.25g
• Colbalt 2.2g
• Iodine 0.76g
• Selenium 0.5g

Formulation Type: Aqueous suspension

General Use Claims:
For the treatment and control of mature and immature gastrointestinal roundworms in sheep, including those with single or dual resistance to benzimidazoles, levamisole or closantel.

It is also effective against lungworm, tapeworm, mature and late immature liver fluke, nasal bot and itch mite.

Bomatak LAC Sheep Oral Mineralised has a persistent activity of up to 42 days against Haemonchus contortus.

Any person may make a written submission to the director-general concerning this application. Under sections 16 and 17 of the Agricultural Compounds and Veterinary Medicines Act 1997, a written submission:

(a) must state in full the reasons for making the submission; and

(b) may state any decision sought on that application; and

(c) must be received by the director-general no later than 30 working days after the date of notification in the New Zealand Gazette.

A copy of every submission will be forwarded to the applicant for the applicant’s information.

The following address is:

(a) where submissions on this application are to be sent;

and

(b) where requests for copies of the public information relating to the application can be sent;

and

(c) where public information relating to the application can be viewed;

and

(d) the director-general’s address for service:

ACVM Group, New Zealand Food Safety Authority, Level 5, South Tower, 68–86 Jervois Quay, Wellington 6011. Postal Address: PO Box 2835, Wellington 6140.

The applicant’s address for service is:

Bomac Laboratories Limited, corner of Wiri Station Road and Hobill Avenue, Wiri, Manukau 2104. Postal Address: PO Box 76369, Manukau City, Manukau 2241.

Dated at Wellington this 22nd day of August 2008.

MAREE ZINZLEY, Programme Manager (Operations) (acting under delegated authority).

go6217

Notice of Application to Register a Trade Name Product (Notice No. 96)

Pursuant to section 14(1) of the Agricultural Compounds and Veterinary Medicines Act 1997, the Director-General of the New Zealand Food Safety Authority gives notice that the following application has been made to register a trade name product under section 9(1) of the Agricultural Compounds and Veterinary Medicines Act 1997:

Trade Name: Ultravac 6 In 1

Reference: A10191

Active Ingredients:

• Clostridium perfringens type D UF toxoid concentrate
• Clostridium tetani UF toxoid concentrate
• Clostridium novyi type B UF toxoid concentrate
• Clostridium septicum UF toxoid concentrate
• Clostridium chauvoei formol culture concentrate
• Clostridium sordellii formol culture concentrate

Formulation Type: Aqueous solution or suspension

General Use Claims:
For the prevention of enterotoxaemia (pulpy kidney disease), tetanus, black disease, malignant oedema (black-like disease) and blackleg in sheep and cattle, including swelled head in rams.

For active immunisation of sheep and cattle to Clostridium sordellii, a cause of sudden death syndrome.

Any person may make a written submission to the director-general concerning this application. Under sections 16 and 17 of the Agricultural Compounds and Veterinary Medicines Act 1997, a written submission:

(a) must state in full the reasons for making the submission; and

(b) may state any decision sought on that application; and

(c) must be received by the director-general no later than 30 working days after the date of notification in the New Zealand Gazette.

A copy of every submission will be forwarded to the applicant for the applicant’s information.

The following address is:

(a) where submissions on this application are to be sent;

and

(b) where requests for copies of the public information relating to the application can be sent;

and

(c) where public information relating to the application can be viewed;

and

(d) the director-general’s address for service:

ACVM Group, New Zealand Food Safety Authority, Level 5, South Tower, 68–86 Jervois Quay, Wellington 6011. Postal Address: PO Box 2835, Wellington 6140.